Literature DB >> 27470356

miR-204-5p regulates cell proliferation and metastasis through inhibiting CXCR4 expression in OSCC.

Xinjuan Wang1, Fujun Li2, Xiaoli Zhou2.   

Abstract

MicroRNAs (miRNAs) are important small molecules in cancer including oral squamous cell carcinoma (OSCC) which regulate gene expression at post-transcriptional levels. MiR-204-5p acts as a tumor suppressor in some of cancers, but the role of it in OSCC is not known. The aim of this study is to investigate the expression and functional roles of miR-204-5p in OSCC. The results showed that the expression of miR-204-5p was lower in cancer tissues or cells. Next, cell proliferation, cell cycle, migration and invasion were detected. It was found that miR-204-5p could enhance OSCC cell proliferation and metastasis. MiR-204-5p was predicted as a regulatory miRNA of CXCR4 in OSCC, and the data analysis indicated that there was a negatively relationship between miR-204-5p and CXCR4 expression in OSCC tissues from the patients. In a conclusion, our findings suggested that miR-204-5p may function as an inhibitory RNA molecule in OSCC by targeting CXCR4.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  CXCR4; OSCC; miR-204-5p

Mesh:

Substances:

Year:  2016        PMID: 27470356     DOI: 10.1016/j.biopha.2016.04.060

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  22 in total

1.  Identifying and targeting angiogenesis-related microRNAs in ovarian cancer.

Authors:  Xiuhui Chen; Lingegowda S Mangala; Linda Mooberry; Emine Bayraktar; Santosh K Dasari; Shaolin Ma; Cristina Ivan; Karem A Court; Cristian Rodriguez-Aguayo; Recep Bayraktar; Sangram Raut; Nirupama Sabnis; Xianchao Kong; Xianbin Yang; Gabriel Lopez-Berestein; Andras G Lacko; Anil K Sood
Journal:  Oncogene       Date:  2019-07-09       Impact factor: 9.867

Review 2.  Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy.

Authors:  Weiqiang Zhou; Shanchun Guo; Mingli Liu; Matthew E Burow; Guangdi Wang
Journal:  Curr Med Chem       Date:  2019       Impact factor: 4.530

3.  [Effect of miR-204-5p on the proliferation, migration, and invasion on tongue squamous cell carcinoma SCC25 cells by targeting bromodomain-containing protein 4].

Authors:  Jing Zheng; Yu-Wen Zhang; Tian-Ke Li; Yang Bao; Su-Xin Zhang
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2020-04-01

4.  microRNA-204 modulates chemosensitivity and apoptosis of prostate cancer cells by targeting zinc-finger E-box-binding homeobox 1 (ZEB1).

Authors:  Guanlin Wu; Jian Wang; Guojun Chen; Xing Zhao
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

5.  miR-486-3p, miR-139-5p, and miR-21 as Biomarkers for the Detection of Oral Tongue Squamous Cell Carcinoma.

Authors:  Zujian Chen; Tianwei Yu; Robert J Cabay; Yi Jin; Ishrat Mahjabeen; Xianghong Luan; Lei Huang; Yang Dai; Xiaofeng Zhou
Journal:  Biomark Cancer       Date:  2017-01-09

6.  miR-204-5p and miR-3065-5p exert antitumor effects on melanoma cells.

Authors:  Nadezhda Palkina; Anna Komina; Maria Aksenenko; Anton Moshev; Andrei Savchenko; Tatiana Ruksha
Journal:  Oncol Lett       Date:  2018-04-05       Impact factor: 2.967

7.  Expression and potential molecular mechanisms of miR‑204‑5p in breast cancer, based on bioinformatics and a meta‑analysis of 2,306 cases.

Authors:  Kai-Teng Cai; An-Gui Liu; Ze-Feng Wang; Hang-Wei Jiang; Jing-Jing Zeng; Rong-Quan He; Jie Ma; Gang Chen; Jin-Cai Zhong
Journal:  Mol Med Rep       Date:  2018-12-14       Impact factor: 2.952

Review 8.  CXCL12 Signaling in the Tumor Microenvironment.

Authors:  Luigi Portella; Anna Maria Bello; Stefania Scala
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  MicroRNA-542-3p inhibits oral squamous cell carcinoma progression by inhibiting ILK/TGF-β1/Smad2/3 signaling.

Authors:  Bin Qiao; Jing-Hua Cai; Alfred King-Yin Lam; Bao-Xia He
Journal:  Oncotarget       Date:  2017-08-07

10.  Loss of miR-204-5p Promotes Tumor Proliferation, Migration, and Invasion Through Targeting YWHAZ/PI3K/AKT Pathway in Esophageal Squamous Cell Carcinoma.

Authors:  Zhimin Shen; Tianci Chai; Fei Luo; Zhun Liu; Hui Xu; Peipei Zhang; Mingqiang Kang; Sui Chen
Journal:  Onco Targets Ther       Date:  2020-05-26       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.